Health / Medical Topics

    Obinutuzumab

    Pronunciation

    Definition 1

    A drug used with another drug to treat chronic lymphocytic leukemia (CLL) that has not already been treated. It is also being studied in the treatment of other types of cancer. Obinutuzumab binds to a protein called CD20, which is found on B cells (a type of white blood cell) and some types of leukemia cells. This may help the immune system kill cancer cells. Obinutuzumab is a type of monoclonal antibody. Also called Gazyva. (NCI Dictionary)

    Definition 2

    A glycoengineered, humanized IgG1 monoclonal antibody with potential antineoplastic activity. Afutuzumab, a third generation type II anti-CD20 antibody, selectivity binds to the extracellular domain of the human CD20 antigen on malignant human B cells. The Fc region carbohydrates of the antibody, enriched in bisected non-fucosylated glycosylation variants, contribute to its higher binding affinity for human FcgammaRIII receptors compared to non-glycoengineered antibodies, resulting in enhanced antibody-dependent cellular cytotoxicity (ADCC) and caspase-independent apoptosis. In addition, modification of elbow hinge sequences within the antibody variable framework regions may account for the strong apoptosis-inducing activity of R7159 upon binding to CD20 on target cells. (NCI Thesaurus)




    YOU MAY ALSO LIKE

    The location of the brain that corresponds to the narrowing of the fourth ventricle into the central canal of the spinal…
    Obesity means having too much body fat. It is different from being overweight, which means weighing too much. Both terms mean that…
    Nuclear hormone receptors are transcription factors that bind DNA and regulate transcription in a ligand-dependent manner. PPAR-gamma is a member of…
    A condition marked by an abnormally high, unhealthy amount of body fat.
    Having an abnormally high, unhealthy amount of body fat.
    A substance being studied in the treatment of several types of cancer. It is a form of obatoclax, which blocks the activity…

    © 1991-2023 The Titi Tudorancea Bulletin | Titi Tudorancea® is a Registered Trademark | Terms of use and privacy policy
    Contact